Elizabeth H.Z. Thompson, Ph.D., has informed Acadia Pharmaceuticals of her planned retirement from the role of Executive Vice President, Head of Research and Development, effective October 23, 2026. Following her retirement, Dr
Who to call at Acadia Pharmaceuticals, and when
A new leader at Acadia Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Acadia Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Acadia Pharmaceuticals, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Acadia Pharmaceuticals
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. The company aims to deliver therapies that transform the lives of patients. With a strong commitment to research and development, Acadia is dedicated to advancing science and addressing key health challenges.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Acadia Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
